Related Experiment Videos
Central Nervous System Coccidioides immitis Infections
1Neurology Service, New Mexico VA Health Care System, 1501 San Pedro Drive SE, Albuquerque, NM 87108, USA. LEDavis@unm.edu.
Current Treatment Options in Neurology
|January 29, 2005
Summary
Coccidioidal meningitis, a fungal infection of the brain, affects immunocompromised individuals. While diagnosis can be difficult, antibody tests are effective, and new treatments like liposomal amphotericin B show promise.
Area of Science:
- Mycology
- Infectious Diseases
- Neurology
Background:
- Coccidioidal meningitis is a serious central nervous system infection caused by the fungus Coccidioides immitis.
- It often arises from a primary lung infection and disseminates to the meninges, particularly in endemic areas like the Lower Sonoran Life Zone.
- The condition can affect both healthy individuals and those with compromised immune systems, including patients with AIDS.
Purpose of the Study:
- To review the epidemiology, diagnosis, and treatment of coccidioidal meningitis.
- To highlight diagnostic challenges and the utility of serological tests.
- To discuss current and potential therapeutic strategies, including novel antifungal agents.
Main Methods:
- Literature review of coccidioidal meningitis cases and treatment outcomes.
- Analysis of diagnostic methods, focusing on cerebrospinal fluid analysis and serological testing.
- Evaluation of current and investigational treatment regimens, including oral and intravenous antifungal therapies.
Main Results:
- Coccidioidal meningitis diagnosis is often challenging, with C. immitis isolated from cerebrospinal fluid in less than 50% of cases.
- A cerebrospinal fluid complement fixation test for IgG antibody to C. immitis demonstrates high sensitivity and specificity for diagnosis.
- Optimal treatment remains unclear, with standard therapies including fluconazole or amphotericin B, while liposomal amphotericin B shows potential due to improved properties.
Conclusions:
- Coccidioidal meningitis requires prompt diagnosis and management, often necessitating long-term antifungal therapy.
- While diagnostic tools like antibody testing are valuable, further comparative studies are needed to establish the optimal treatment regimen.
- Liposomal amphotericin B presents a promising alternative for initial treatment due to its favorable pharmacokinetic and safety profile compared to conventional amphotericin B.